The Enterprise Value as of December 2025 (TTM) for Tasly Pharmaceutical Group Co., Ltd (600535.SS) is 21.14B

According to Tasly Pharmaceutical Group Co., Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 21.14B. This represents a change of 1.06% compared to the average of 20.92B of the last 4 quarters.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Historical Enterprise Value (quarterly & annually)

How has 600535.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Tasly Pharmaceutical Group Co., Ltd over the last ten years is 30.61B. The current 21.14B Enterprise Value has changed 6.81% with respect to the historical average. Over the past ten years (40 quarters), 600535.SS's Enterprise Value was at its highest in in the March 2018 quarter at 56.33B. The Enterprise Value was at its lowest in in the September 2022 quarter at 15.01B.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tasly Pharmaceutical Group Co., Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Average Enterprise Value

How has 600535.SS Enterprise Value performed in the past?

The current Enterprise Value of Tasly Pharmaceutical Group Co., Ltd (600535.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Tasly Pharmaceutical Group Co., Ltd (600535.SS) Enterprise Value vs. Peers

How is 600535.SS’s Enterprise Value compared to its peers?

Tasly Pharmaceutical Group Co., Ltd’s Enterprise Value is less than Hubei Jumpcan Pharmaceutical Co., Ltd. (21.35B), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (14.20B), greater than China National Medicines Corporation Ltd. (16.74B), less than Jiangsu Nhwa Pharmaceutical Co., Ltd. (23.41B), less than Jilin Aodong Pharmaceutical Group Co., Ltd. (23.50B), greater than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.14B), less than ApicHope Pharmaceutical Co., Ltd (22.63B), less than Betta Pharmaceuticals Co., Ltd. (22.15B), greater than Apeloa Pharmaceutical Co.,Ltd (17.95B), greater than Autobio Diagnostics Co., Ltd. (20.50B),

Build a custom stock screener for Tasly Pharmaceutical Group Co., Ltd (600535.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tasly Pharmaceutical Group Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tasly Pharmaceutical Group Co., Ltd (600535.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tasly Pharmaceutical Group Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.